Ospovat I - Search Results

1

Expect the unexpected: peritoneal spread--late relapse presentation of breast cancer.

Katz D, Peretz T, Maly B, Ospovat I, Salim N, Ramu N, Hovav N, Uziely B. Katz D, et al. Among authors: ospovat i. Isr Med Assoc J. 2008 Apr;10(4):310-1. Isr Med Assoc J. 2008. PMID: 18548989 Free article. No abstract available.

2

Mitomycin C and vinblastine: an active regimen in previously treated breast cancer patients.

Ospovat I, Siegelmann-Danieli N, Grenader T, Hubert A, Hamburger T, Peretz T. Ospovat I, et al. Tumori. 2009 Nov-Dec;95(6):683-6. doi: 10.1177/030089160909500607. Tumori. 2009. PMID: 20210229

3

[Ctla-4 blockade: a new hope for the immunotherapy of malignant melanoma].

Lotem M, Merims S, Frank S, Ospovat I, Peretz T. Lotem M, et al. Among authors: ospovat i. Harefuah. 2012 Oct;151(10):585-8, 604. Harefuah. 2012. PMID: 23316667 Review. Hebrew.

4

Gemcitabine in combination with paclitaxel for advanced soft-tissue sarcomas.

Sonnenblick A, Eleyan F, Peretz T, Ospovat I, Merimsky O, Sella T, Peylan-Ramu N, Katz D. Sonnenblick A, et al. Among authors: ospovat i. Mol Clin Oncol. 2015 Jul;3(4):829-832. doi: 10.3892/mco.2015.545. Epub 2015 Apr 16. Mol Clin Oncol. 2015. PMID: 26171190 Free PMC article.

5

Aortic occlusion in patients treated with Cisplatin-based chemotherapy.

Grenader T, Shavit L, Ospovat I, Gutfeld O, Peretz T. Grenader T, et al. Among authors: ospovat i. Mt Sinai J Med. 2006 Sep;73(5):810-2. Mt Sinai J Med. 2006. PMID: 17008944

6

HLA-B35 correlates with a favorable outcome following adjuvant administration of an HLA-matched allogeneic melanoma vaccine.

Lotem M, Kadouri L, Merims S, Ospovat I, Nissan A, Ron I, Frankenburg S, Machlenkin A, Israel S, Steinberg H, Hamburger T, Peretz T. Lotem M, et al. Among authors: ospovat i. Tissue Antigens. 2011 Sep;78(3):203-7. doi: 10.1111/j.1399-0039.2011.01709.x. Epub 2011 Jun 7. Tissue Antigens. 2011. PMID: 21644933

7

Extrapulmonary Small Cell Cancer: A New Insight into a Rare Disease.

Brazg Ferro L, Wolf I, Peleg Hasson S, Golomb I, Osher E, Berlin A, Gutfeld O, Ospovat I, Soyfer V. Brazg Ferro L, et al. Among authors: ospovat i. Oncology. 2021;99(6):373-379. doi: 10.1159/000514520. Epub 2021 Mar 26. Oncology. 2021. PMID: 33774637

8

Next-generation sequencing in salivary gland carcinoma: Targetable alterations lead to a therapeutic advantage-Multicenter experience.

Moore A, Bar Y, Maurice-Dror C, Ospovat I, Sarfaty M, Korzets Y, Goldvaser H, Gordon N, Billan S, Gutfeld O, Popovtzer A. Moore A, et al. Among authors: ospovat i. Head Neck. 2020 Apr;42(4):599-607. doi: 10.1002/hed.26026. Epub 2019 Nov 24. Head Neck. 2020. PMID: 31762146

9

Personalized radiation dosimetry for PRRT-how many scans are really required?

Freedman N, Sandström M, Kuten J, Shtraus N, Ospovat I, Schlocker A, Even-Sapir E. Freedman N, et al. Among authors: ospovat i. EJNMMI Phys. 2020 May 11;7(1):26. doi: 10.1186/s40658-020-00293-z. EJNMMI Phys. 2020. PMID: 32394075 Free PMC article.

10

Towards homogenization of total body irradiation practices in pediatric patients across SIOPE affiliated centers. A survey by the SIOPE radiation oncology working group.

Hoeben BAW, Pazos M, Albert MH, Seravalli E, Bosman ME, Losert C, Boterberg T, Manapov F, Ospovat I, Milla SM, Abakay CD, Engellau J, Kos G, Supiot S, Bierings M, Janssens GO. Hoeben BAW, et al. Among authors: ospovat i. Radiother Oncol. 2021 Feb;155:113-119. doi: 10.1016/j.radonc.2020.10.032. Epub 2020 Nov 1. Radiother Oncol. 2021. PMID: 33137397 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters